Arcus Biosciences (RCUS) Non-cash Items (2016 - 2022)
Arcus Biosciences (RCUS) recorded quarterly Non-cash Items of $6.7 million in Q4 2022, down 97.36% quarter-over-quarter from $253.6 million in Q4 2021, and down 97.36% on a YoY basis from $253.6 million in Q4 2021.
Arcus Biosciences (RCUS) Non-cash Items (2016 - 2022) Analysis & Trends
Arcus Biosciences' Non-cash Items history runs 7 years deep, the most recent figure standing at $6.7 million for Q4 2022.
- In Q4 2022, Non-cash Items fell 97.36% year-over-year to $6.7 million; the TTM figure through Dec 2022 stood at $6.7 million (down 97.36% YoY), while the FY2022 annual figure was $6.7 million, down 97.36% from the prior year.
- Non-cash Items was $6.7 million for Q4 2022 at Arcus Biosciences, down from $253.6 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $253.6 million in Q4 2021 to a low of $238721.0 in Q4 2018.
- Historically, Non-cash Items has averaged $81.3 million across 5 years, with a median of $23.7 million in 2019.
- The sharpest annual moves came in 2019 and 2022: Non-cash Items surged 9827.91% in 2019, then plunged 97.36% in 2022.
- A 5-year view of Non-cash Items shows it stood at $238721.0 in 2018, then soared by 9827.91% to $23.7 million in 2019, then surged by 415.75% to $122.2 million in 2020, then surged by 107.49% to $253.6 million in 2021, then slumped by 97.36% to $6.7 million in 2022.
- The last three Non-cash Items figures came in at $6.7 million (Q4 2022), $253.6 million (Q4 2021), and $122.2 million (Q4 2020), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcus Biosciences | 3.05 Bn | 2.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 6.70 Mn |
| Dec 31, 2022 | 6.70 Mn |
| Dec 31, 2021 | 253.62 Mn |
| Dec 31, 2021 | 253.62 Mn |
| Dec 31, 2020 | 122.23 Mn |
| Dec 31, 2020 | 122.23 Mn |
| Dec 31, 2019 | 23.70 Mn |
| Dec 31, 2019 | 23.70 Mn |
| Dec 31, 2018 | 238,721.00 |
| Dec 31, 2018 | 238,721.00 |
| Dec 31, 2017 | 1.90 Mn |
| Dec 31, 2017 | 1.90 Mn |
| Dec 31, 2016 | 400,000.00 |
| Dec 31, 2016 | 400,000.00 |